A 52-year-old man from Delhi presents with progressive muscle weakness and fasciculations over 3 months. He works in a pesticide factory and reports accidental exposure to organophosphate compounds 6 weeks ago. On examination, he has miosis, excessive salivation, and muscle twitching. Serum acetylcholinesterase levels are found to be 30% of normal. Which type of enzyme inhibition best explains the persistent reduction in acetylcholinesterase activity despite discontinuation of pesticide exposure?

Explanation

## Organophosphate Poisoning and Enzyme Inhibition Mechanism ### Clinical Context Organophosphate compounds (found in pesticides) cause irreversible inhibition of acetylcholinesterase (AChE), leading to accumulation of acetylcholine at neuromuscular junctions and cholinergic crisis. ### Type of Inhibition: Irreversible Non-Competitive **Key Point:** Organophosphates form a covalent phosphoester bond with the serine hydroxyl group (Ser203) in the active site of AChE. This is a **non-competitive, irreversible inhibition** because: - The inhibitor binds covalently to the enzyme - The bond cannot be broken by increasing substrate concentration - The enzyme is permanently inactivated - New enzyme synthesis is required for recovery (takes weeks to months) ### Mechanism of Phosphorylation 1. Organophosphate attacks the serine residue at the active site 2. Forms a stable phosphoester bond (covalent linkage) 3. Prevents acetylcholine hydrolysis 4. Causes acetylcholine accumulation → cholinergic toxidrome ### Why This Is Non-Competitive | Feature | Reversible Competitive | Irreversible Non-Competitive | |---------|----------------------|------------------------------| | Binding | Active site, reversible | Covalent, permanent | | Effect of ↑ Substrate | Inhibition overcome | Inhibition persists | | Vmax | Unchanged | Decreased | | Km | Increased | Unchanged | | Recovery | Immediate (enzyme-inhibitor dissociates) | Slow (new enzyme synthesis required) | **High-Yield:** The key distinguishing feature is that the patient's AChE remains depressed even after exposure ends — this is pathognomonic for irreversible inhibition. ### Clinical Correlation **Clinical Pearl:** The "aging" of organophosphate-AChE complex occurs when the phosphoester bond loses an alkyl group, making it even more resistant to reactivation. This is why pralidoxime (2-PAM) must be given early — it can only reactivate the enzyme before aging occurs. **Mnemonic:** **OPIE** = **O**rganophosphate **P**oisons cause **I**rreversible **E**nzyme inhibition (via covalent phosphorylation of serine). [cite:KD Tripathi 8e Ch 12]